Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Cats likely have a reactive skin condition, while dogs may have a more complex, possibly cancerous one.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Gamma/delta T cells help defend skin against heavy metals.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

ILC1 cells contribute to hair loss in alopecia areata.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

IL-18 signaling helps mature Tregs move into the thymus.

Treg cells help repair and regenerate tissues by interacting with local cells.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Tislelizumab can cause cutaneous lupus erythematosus.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.